Day One Biopharmaceuticals
DAWN
DAWN
164 hedge funds and large institutions have $1.19B invested in Day One Biopharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 39 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-1
Holders Change %
-0.61%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
33
Increased
62
Reduced
39
Closed
33
Calls
$2.08M
Puts
$3.36M
Net Calls
-$1.28M
Net Calls Change
+$713K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$69.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$31.8M |
| 3 |
BlackRock
New York
|
+$18.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$13.9M |
| 5 |
ECM
Estuary Capital Management
Wayzata,
Minnesota
|
+$12.3M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$35.6M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$29.4M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$26.8M |
| 4 |
Goldman Sachs
New York
|
-$16.5M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$13.4M |
